When was Illumi Medical founded?

Illumi Medical was founded in 2023 and raised its 1st funding round 1 year after it was founded.

Where is Illumi Medical located?

Illumi Medical is headquartered in Nagoya, Japan.

Is Illumi Medical a funded company?

Illumi Medical is a funded company, having raised a total of $5.69M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 01, 2024.

When was the latest funding round of Illumi Medical?

Illumi Medical's latest funding was a $***** Series A round on Apr 30, 2026, with participation from 3 investors.

Where does Illumi Medical rank among its competitors?

Illumi Medical ranks 2nd amongst 15 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Illumi Medical, which secured $2.26M in Oct, 2025.

Who are the top competitors of Illumi Medical?

Illumi Medical's top competitors include PhotoPharmics, ImPact Biotech and CranioVation. Among them, Illumi Medical secured the most recent funding round in April, 2026.

Illumi Medical - 2026 Company Profile, Funding & Competitors

Illumi Medical is a series A company based in Nagoya (Japan), founded in 2023. It operates as a Developer of photodynamic therapy device for the treatment of cancer. Illumi Medical has raised $5.69M in funding from investors like Ogaki Kyoritsu Bank, MTG Ventures and UntroD. The company has 15 active competitors, including 4 funded and 2 that have exited. Its top competitors include companies like PhotoPharmics, ImPact Biotech and CranioVation.

Company Details

Developer of photodynamic therapy device for the treatment of cancer. The company developing the intravascular light irradiation system "ET-BLIT," which delivers light to target tissues for the treatment of cancer such as lung cancer, pancreatic cancer, brain tumors, and other cancers.

Key Metrics

Founded Year

2023

Location

Nagoya, Japan

Stage

Series A

Total Funding

$5.69M in 3 rounds

Latest Funding Round

Series A, Apr 30, 2026, $*****

Investors

Ogaki Kyoritsu Bank & 8 more

Ranked

2^nd among 15 active competitors

Similar Companies

PhotoPharmics & 19 more

View Illumi Medical's full profile

Illumi Medical has raised a total funding of $5.69M over 3 rounds. Its first funding round was on Apr 01, 2024. Its latest funding round was a Series A round on Apr 30, 2026 for $*****. 3 investors participated in its latest round. Illumi Medical has 9 institutional investors.

Here is the list of recent funding rounds of Illumi Medical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 30, 2026	1637380	Series A	9816058	6509899	7865220	7198459
Oct 20, 2025	7444650	Series A	6164900	7766383	1270375	UntroD & 3 more
Apr 01, 2024	6771071	Seed	6093014	9312147	MTG Ventures & 2 more	Mintco

Access funding benchmarks and valuations. Sign up today!

View details of Illumi Medical's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Illumi Medical include PhotoPharmics, ImPact Biotech and CranioVation. Here is the list of Top 10 competitors of Illumi Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PhotoPharmics 2011, American Fork (United States), Series B	Developer of non-invasive phototherapy for Parkinson's disease	$45.7M	Kickstart Fund, Frazier Group & 6 others	55/100
2nd	Illumi Medical 2023, Nagoya (Japan), Series A	Developer of photodynamic therapy device for the treatment of cancer	$5.69M	SMBC Venture Capital, Ogaki Kyoritsu Bank ... & 7 others	52/100
3rd	ImPact Biotech 2022, Ness Ziona (Israel), Funding Raised	Developer of a drug delivery platform for the treatment of solid tumors	-	-	40/100
4th	CranioVation 2017, Rochester (United States), Acquired	Provider of devices for the minimally invasive treatment of brain tumors	$7.61M	Orbimed	39/100
5th	Adgero Biopharma 2012, Princeton (United States), Acquired	Developer of photodynamic therapy for cutaneous metastatic breast cancer	$5.52M	SRG, HHS & 1 others	38/100
6th	Incando Therapeutics 2019, Belmont (United States), Unfunded	Developer of phototherapy system for the treatment of cancer	-	-	34/100
7th	Lumeda 2020, Rocky Hill (United States), Series A	Developer of photodynamic therapy device for treating lung cancer	$5.34M	Connecticut Innovations, Cycle Capital	33/100
8th	Ascension Onco-Therapeutics 2024, Singapore (Singapore), Unfunded	Developer of a medical device for the treatment of cancer	-	-	30/100
9th	SpectraCure 2003, Lund (Sweden), Funding Raised	Developer of Interstitial photo dynamic therapy for solid tumours	-	Cardeon, Europa	28/100
10th	Photolitec 2010, Buffalo (United States), Deadpooled	Photosensitizing compounds for tumor imaging and image-guided photodynamic cancer therapy.	$5M	Huahai Pharmaceutical, Zhejiang Hisun Pharmaceuticals ... & 2 others	28/100